1-3 of 3
chemokine receptor antagonists
Close
Sort by
Journal Articles

Oncostatin M Is a Novel Niche Factor That Restrains Hematopoietic Stem Cell Mobilization in Response to G-CSF and CXCR4 Antagonist Plerixafor

Kavita Bisht, PhD, Crystal McGirr, Kylie A Alexander, Whitney Fleming, Natalie Sims, Gerhard Müller- Newen, Ingrid G Winkler, PhD, Jean-Pierre Levesque, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4469.
https://doi.org/10.1182/blood-2019-127431
Published: 2019
Journal Articles

Lower Doses of Plerixafor Use Is Sufficient to Effectively Mobilize PBSC (Peripheral Blood Hematopoetic Stem Cells) When Compared to Standard Administration

Hakan Goker, MD, Eylem Eliacik, MD, Fevzi Altuntas, MD, Emre Tekgunduz, MD, Evren Ozdemir, MD, Ayse Isik, MD, Omur Kayikci, MD, Ali Hakan Kaya, MD, Salih Aksu, MD, Ibrahim C. Haznedaroglu, MD, Nilgun Sayinalp, MD, Haluk Demiroglu, Osman Ilhami Ozcebe, MD, Yahya Buyukasik, MD
Journal: Blood
Blood (2014) 124 (21): 5830.
https://doi.org/10.1182/blood.V124.21.5830.5830
Published: 2014
Journal Articles

Kinetics of Stem Cell and Lymphoid Subset Mobilization in Response to Intravenous (IV) AMD3100 in Mouse and Man.

Michael P. Rettig, PhD, Pablo Ramirez, M.D., William D. Shannon, Ph.D., Geoffrey L. Uy, M.D., Sandra Lopez, Julie K. Ritchey, John F. DiPersio, M.D./Ph.D.
Journal: Blood
Blood (2007) 110 (11): 1203.
https://doi.org/10.1182/blood.V110.11.1203.1203
Published: 2007